Bicycle Therapeutics plc — Income Charts
2 years of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue
$73M
R&D
$240M
D&A
$6M
Operating Income
$-247M
EBITDA
$-241M
Interest Expense
$206K
Other Income/Expense
$28M
Pretax Income
$-219M
Tax Provision
$152K
Net Income
$-219M
Operating Margin
-340.4%
Net Margin
-301.7%
Effective Tax Rate
-0.1%
DTA Valuation Allowance
$127M
Tax Credit Carryforwards
$4M
NOL Carryforwards
$101M
ETR (Continuing Operations)
-0.1%
ETR Federal Statutory
25.0%
ETR Foreign Differential (pp)
-6.3%
Operating Lease Cost
$5M
Revenue YoY Variation
105.8%
Income YoY Variation
-17.7%